Germitec’s mission is to improve the standard of care by reducing cross-contamination risk and offering healthcare professionals with an automated solution that is fast, simple, safe, and environmentally friendly.
Germitec has raised €29M across 1 funding round from 2 investors, most recently a round in Feb 2025. Based in Bordeaux, France; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-02-12 | Other | €29M |
| Eurazeo,historical shareholders |
| View deal → |
